ArticleClinical and molecular allergy : CMA2021

Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis.

Giorgio Walter Canonica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.